COVID-19 has hit provider organizations hard with challenges including lost revenue, reduced staff, and uncontrolled chronic conditions while the most critical patients avoid care. Population health leaders, especially those in value-based contracts, face a fourth challenge: rising-risk patients.
Under the status quo, providers rely on manual traditional care management and device-based technology that does not scale to reach sufficient populations. As a result, providers lack the ability to proactively reach a large and costly population-rising-risk patients, and lose timely opportunities to bend the cost curve and prevent rising-risk patients from becoming high-cost utilizers.
Simply put: It’s not enough to focus on high-risk patients alone.
Read our white paper to learn 5 Strategies for Improving Clinical and Financial Outcomes During and Post-Pandemic, as well as real life examples how CareSignal client-partners have successfully implemented these strategies and scaled Deviceless RPM.
By filling out this form you are opting in to receive communications from MedCity News and its partners.
